SEC Form 4 · accession 0001209191-15-080274
HARVARD BIOSCIENCE INC · HBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert E. Gagnon
Officer — Chief Financial Officer
Period of report
Nov 12, 2015
Accepted (ET)
Nov 16, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001123494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 12, 2015 | P | 1,500 | $2.93 | A | 67,721 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes (a) a deferred stock award of 26,500 restricted stock units which shall vest in four equal installments on January 1, 2016, 2017, 2018 and 2019; (b) a deferred stock award of 28,117 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 13,104 shares of common stock held by the Reporting Person.
Remarks
This form has been signed under power of attorney.